Ryan Higgins joins AHLA for a conversation about what a HIPAA Security Rule Risk Analysis (HSRA) is and what it means to conduct an “OCR-compliant” risk analysis. They discuss how an HSRA relates to other security assessments, suggestions for organizations to follow when conducting an HSRA, and the risks of failing to conduct an HSRA.

Learn more and listen here.

The board’s executive compensation committee is the focus point for many of the extraordinary financial, economic and operating challenges currently facing healthcare organizations. Executive compensation increases are impacted by both an inflationary economy and significant revenue downturn. In addition, the Department of Justice has identified executive compensation as an important conduit through by which corporate compliance incentives and deterrence can be implemented. Furthermore, executive recruitment and retention amidst the “Great Resignation” remains a key compensation concern.

These and similar issues have become important agenda items for the board’s executive compensation Committee. Michael Peregrine is joined by industry experts Tim Cotter and Ralph DeJong for the first in a two-part conversation about the impact of the developments on the compensation committee, including:

• Key topics for briefing the board’s compensation committee.
• Increasing communication between the compensation committee and the C-Suite.
• Addressing pressures felt by executive committee members.
• Insights from the Sullivan Cotter compensation data survey.
• Projections for the impact of inflation on next year’s salary increases.
• Expectations for future CEO salary increases and organization departures.
• The segmenting approach to leadership plans.
• Coordination with the Audit & Compliance Committee on compensation incentives

In the 12th episode of Season 2: Driving the Deal, Farragut Square Group’s (FSG) Brian Fortune and Jackie Williams are joined by Holly Stokes, senior research associate at FSG, for a discussion on the future of physician practice management (PPM). Specifically, the trio delves into the regulatory actions that occurred within the PPM sector this past year as we head into end-of-year legislation and rulemaking, as well as the anticipated pressures for market participants in 2023 and 2024. In this episode, they also talk about:

• Regulatory changes for PPM companies
• Proposed cuts to the Physician Fee Schedule
• Implications of the ruling in Dobbs v. Jackson Women’s Health Organization on the fertility and OBGYN sectors
• Drug pricing provisions in the Inflation Reduction Act of 2022
• Future implementation of the No Surprises Act and qualifying payment amount calculation

In the 11th episode of Season 2: Driving the Deal, Krist Werling, McDermott partner and co-head of the Private Equity Practice Group, and Brian Fortune, senior managing director at Farragut Square Group, are joined for a guest interview hosted by Farragut Square Group’s own Jackie Williams and Hope Amsterdam. In this episode, Hope and Jackie interview Damon Terzaghi, senior director of LTSS policy at the National Association of States United for Aging and Disabilities, to provide an overview of the home- and community-based services (HCBS) space. Together, they discuss the following:

• The increase in demand for HCBS before and after COVID-19
• The increased Federal Medical Association Percentages reimbursement for HCBS
• The likelihood of increased funding to exist beyond the public health emergency
• Labor issues surrounding the HCBS space
• Priorities for states surrounding HCBS after the pandemic

In the 10th episode of Season 2: Driving the Deal, Krist Werling, McDermott partner and co-head of the Private Equity Practice Group, and Brian Fortune, senior managing director at Farragut Square Group, are joined by Mark Francis, managing director at Houlihan Lokey and head of its Healthcare Group, as they summarize the end of Q2 for the healthcare industry. Together, they discuss the following:

• Healthcare sectors poised to see an increase in deal volume and activity
• A review of activity and deal flow in Q1 and Q2
• Sectors that are cooling off post-Q1 and Q2
• The impact of digital health on the healthcare industry
• Sectors heading into distress territory
• Q3 insights

In episode 9 of Season 2: Driving the Deal, Brian Fortune, senior managing director at Farragut Square Group (FSG), is joined by Elle Kalisz, a research analyst at FSG, and Swatee Survee, CEO and founder of Litesprite. Together, they explore all things digital technology, including:

• What is a Digital Therapeutic?
• What makes a Digital Therapeutic different from traditional digital health tools?
• The intersection of digital self-help tools and mobile gaming.
• Provider, payor and employer uptake/participation.
• Insights for investors interested in the digital technology space.

In Season 2, Episode 7 of Driving the Deal, Krist Werling, McDermott partner and co-head of the Firm’s Private Equity Practice Group, and Brian Fortune, senior managing director at Farragut Square Group, are joined by Brian Stimson, a partner in McDermott’s Healthcare Practice Group and former Acting General Counsel and Principal Deputy General Counsel for the US Department of Health and Human Services. Together they discuss current litigation surrounding the impending future of the No Surprises Act, as well as:

• The specialties most impacted by the legislation and subsequent litigation
• An overview of the No Surprises Act and current litigation surrounding it
• The Act’s impact on providers
• Next steps for future litigation